Risk factors for elevated blood lead levels among children aged 6-36 months living in Greece

A Kapitsinou1, A Soldatou1, A Tsitsika1

  • 1Second Department of Pediatrics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Insights

Childhood lead poisoning is a significant health risk in Greece, particularly for toddlers and children from disadvantaged families. Factors like living conditions and maternal occupation are linked to elevated blood lead levels (BLLs).

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Public Health

Background:

  • Childhood lead poisoning is a critical environmental health issue with irreversible effects.
  • Social and environmental factors are associated with elevated blood lead levels (BLLs).
  • No recent data exists on BLLs prevalence in Greek children.

Purpose of the Study:

  • To assess BLLs in children aged 6-36 months in Greece.
  • To identify demographic, socio-economic, and housing factors associated with BLLs.

Main Methods:

  • A cross-sectional hospital-based study of 814 children (6-36 months).
  • Evaluation of BLLs and hematological parameters.
  • Questionnaire on demographic, socio-economic, and housing conditions.

Main Results:

  • Mean BLLs were 2.78 µg/dL; 11.7% exceeded 5 µg/dL.
  • Risk factors included being a toddler, Roma/Asian ethnicity, industrial/low-income neighborhoods, old housing, traditional herb use, and maternal manual occupation.
  • Elevated BLLs were associated with specific socio-economic and environmental factors.

Conclusions:

  • Lead exposure poses a threat to children's health in Greece, especially for vulnerable groups.
  • Targeted interventions are needed for toddlers and children from disadvantaged families.
  • A nationwide survey is recommended to inform public health policies.
Abstract

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
4.1K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
209
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
353
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499